Parkinson's Disease

Paper Summary:

This paper discusses Parkinson's Disease, providing details of the symptoms that are associated with this progressive illness and some of the therapies that are used in its management.

Outline:
Management of Parkinson's Disease
Conclusion

From the Paper:

"Parkinson's disease (PD) is one of the most common degenerative, movement disorders. There are approximately one million Americans suffering from this disease (Hamai and Lozano, 2003). In the United Kingdom, PD has a prevalence rate of about 1.6 per 1,000. It has been reported to affect 1 in 750 people worldwide. It is less frequent among the Chinese, Japanese, as well as in the black population. Its prevalence increases with age, reaching a peak in the seventh decade. Before the age of 40 years, more men are inflicted with this disease than women. However, by the 7th and 8th decades, 645 to 830 per 100,000 women suffer from PD; on the other hand, only 465 to 736 per 100,000 men develop this disease (Armstrong, 2008). Mortality rate is about 1.6 times more than individuals of the same age. Patients with PD may die secondary to pneumonia or other unrelated disease. Mostly, people with PD die due to direct effects of PD such as decreased mobility, aspiration, or increased falling with subsequent physical injury (Fahn, 2003)."

Sample of Sources Used:

• Armstrong, R. A. (2008). "Visual signs and symptoms of Parkinson's disease." Clinical and Experimental Optometry, 91(2): 129-138.
• Ashburn, A., Fazakarley, L., Ballinger, C., Pickering, R., McLellan, L. D., and Fitton, C. (2007). "A randomized controlled trial of a home based exercise program to reduce the risk of falling among people with Parkinson's disease." Journal of Neurology, Neurosurgery, and Psychiatry, 78: 678-684.
• Blanchet, S., Marie, R. M., Dauvillier, F., Landeau, B., Benali, K., Eustache, F., & Chavoix, C. (2000). "Cognitive processes involved in delayed non-matching-to-sample performance in Parkinson's disease." European Journal of Neurology, 7: 473-483.
• Fahn, S. (2003). "Description of Parkinson's disease as a clinical syndrome." Annals New York Academy of Sciences, 991: 1-14.
• Hamani, C., & Lozano, A. M. (2003). "Physiology and pathophysiology of Parkinson's disease." Annals New York Academy of Sciences, 991: 15-21.

More papers on Parkinson's Disease:

• Term Paper # 86487 : "Parkinson's Disease & Stem Cell Research"
• Analytical Essay # 123782 : "Proteins and Parkinson's Disease"
• Article Review # 121724 : "Parkinson's Disease"
• Comparison Essay # 110564 : "Alzheimer 's Disease Medication"

APA Citation:

MLA Citation: